Decay-Accelerating Factor and Membrane Cofactor Protein

作者: D. M. Lublin , J. P. Atkinson

DOI: 10.1007/978-3-642-74977-3_7

关键词: Complement component 2Factor HCD46BiochemistryDecay-accelerating factorMembrane proteinComplement systemAlternative complement pathwayCell biologyMembrane glycoproteinsBiology

摘要: Cells exposed to plasma proteins are frequently under attack from the complement system. This can arise either as a bystander process classical or alternative pathways of activation initiated during immune response foreign particles and organisms constant tick-over pathway. Thus, it is critical for cell regulate pathway on its own surface. The proteins, H C4 binding protein (C4bp), in conjugation with serine protease I, function this end. Additionally, cells possess number membrane deposited their surfaces; largest group, focused C3 convertases, consists C3b/C4b receptor (CR1), decay-accelerating factor (DAF), cofactor (MCP). CR1, although has both activity serves I-mediated cleavage C3b C4b, acts mainly extrinsically C3b-bearing complexes. DAF exerts intrinsically itself (see below). Indeed, lack blood disease paroxysmal nocturnal hemoglobinuria (PNH) leads an increased sensitivity these cells. Purified MCP also convertases through I activity. same approximate size overall structure DAF, hence might control formed cell. chapter reviews detail structure, at DNA levels, two regulatory glycoproteins, MCP, discusses physiological roles protecting damage by autologous complement.

参考文章(67)
T Kinoshita, S I Rosenfeld, V Nussenzweig, A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes. Journal of Immunology. ,vol. 138, pp. 2994- 2998 ,(1987)
J P Atkinson, L L Ballard, N S Bora, G H Yu, Biochemical characterization of membrane cofactor protein of the complement system. Journal of Immunology. ,vol. 141, pp. 3923- 3929 ,(1988)
K F Austen, A Nicholson-Weller, D A Russian, Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF). Journal of Immunology. ,vol. 137, pp. 1275- 1279 ,(1986)
Dennis Hourcade, V. Michael Holers, John P. Atkinson, The regulators of complement activation (RCA) gene cluster. Advances in Immunology. ,vol. 45, pp. 381- 416 ,(1989) , 10.1016/S0065-2776(08)60697-5
R. Dixit, R. Schneider, S.K. Law, A. Kulczycki, J.P. Atkinson, Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b. Journal of Biological Chemistry. ,vol. 257, pp. 1595- 1597 ,(1982) , 10.1016/S0021-9258(19)68076-2
T Kinoshita, M E Medof, V Nussenzweig, Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. Journal of Immunology. ,vol. 136, pp. 3390- 3395 ,(1986)
K F Austen, P F Weller, A Nicholson-Weller, J Burge, D T Fearon, Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. Journal of Immunology. ,vol. 129, pp. 184- 189 ,(1982)
K F Austen, A Nicholson-Weller, J Burge, Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a. Journal of Immunology. ,vol. 127, pp. 2035- 2039 ,(1981)